Hydrochloric Acid → 4-(1-Isopropyl-2-methylimidazol-5-yl)-2-{4-[N-(2-ethoxyethyl)sulphamoyl]anilino}pyrimidine
Reaction equation
[NH2:1][C:2]1[N:7]=[C:6]([C:8]2[N:12]([CH:13]([CH3:15])[CH3:14])[C:11]([CH3:16])=[N:10][CH:9]=2)[CH:5]=[CH:4][N:3]=1.[CH2:17]([O:19][CH2:20][CH2:21][NH:22][S:23]([C:26]1[CH:31]=[CH:30][C:29](I)=[CH:28][CH:27]=1)(=[O:25])=[O:24])[CH3:18].C1(P(C2C=CC=CC=2)C2C=CC3C(=CC=CC=3)C=2C2C3C(=CC=CC=3)C=CC=2P(C2C=CC=CC=2)C2C=CC=CC=2)C=CC=CC=1.CC(C)([O-])C.[Na+].Cl.CCOCC>O1CCOCC1.CO.[Pd].[Pd].C(=CC(C=CC1C=CC=CC=1)=O)C1C=CC=CC=1.C(=CC(C=CC1C=CC=CC=1)=O)C1C=CC=CC=1.C(=CC(C=CC1C=CC=CC=1)=O)C1C=CC=CC=1>[CH:13]([N:12]1[C:8]([C:6]2[CH:5]=[CH:4][N:3]=[C:2]([NH:1][C:29]3[CH:28]=[CH:27][C:26]([S:23](=[O:24])(=[O:25])[NH:22][CH2:21][CH2:20][O:19][CH2:17][CH3:18])=[CH:31][CH:30]=3)[N:7]=2)=[CH:9][N:10]=[C:11]1[CH3:16])([CH3:14])[CH3:15]Participants
Reactant 6
Product 1
Reagents, catalysts & solvents 3
Conditions
- Temperature
- 80 °C
Procedure
To a stirred solution of 2-amino-4-(1-isopropyl-2-methylimidazol-5-yl)pyrimidine (Method 39; 163 mg, 0.75 mmol), N-(2-ethoxyethyl)-4-iodobenzenesulphonamide (Method 44; 400 mg, 1.13 mmol), tris(dibenzylideneacetone) dipalladium (0) (35 mg, 0.038 mmol) and 2,2′-bis(diphenylphosphino)-1,1′-binaphthyl (47 mg, 0.076 mmol) in dioxane (10 ml) was added sodium t-butoxide (258 mg, 2.69 mmol) and the mixture heated at 80° C. overnight. The reaction was cooled to room temperature and MeOH 105 ml) was added and the mixture poured onto an Isolute SCX-2 column, eluted first with MeOH (10×30 ml) and the product was then eluted with 5% methanolic ammonia (10×30 ml). The solvent was removed by evaporation and the residue purified by flash chromatography on silica gel eluting with DCM/MeOH (100:0 increasing in polarity to 97:3) to yield a foam which was dissolved in MeOH (2 ml) and treated with 1N HCl in ether (350 μl, 0.35 mmol) for 5 minutes. Solvent was evaporated in vacuo to yield a yellow foam which was triturated with ether to yield after filtration the title compound as a yellow solid (141 mg, 39%) NMR: 1.05 (t, 3H), 1.53 (d, 6H), 2.80 (s, 3H), 2.85 (q, 2H), 3.32 (m, 4H), 5.58 (m, 1H),7.21 (d, 1H), 7.52 (t, 1H), 7.73 (d, 2H), 7.86 (d, 2H), 8.39 (s, 1H), 8.68 (d, 1H), 10.18 (brs, 1H); m/z 445.
Workup
- temperatureThe reaction was cooled to room temperature
- additionthe mixture poured onto an Isolute SCX-2 column
- washeluted first with MeOH (10×30 ml)
- washthe product was then eluted with 5% methanolic ammonia (10×30 ml)
- customThe solvent was removed by evaporation
- customthe residue purified by flash chromatography on silica gel eluting with DCM/MeOH (100:0 increasing in polarity to 97:3)
- customto yield a foam which
- customSolvent was evaporated in vacuo
- customto yield a yellow foam which
- customwas triturated with ether
- customto yield
- filtrationafter filtration the title compound as a yellow solid (141 mg, 39%) NMR: 1.05 (t, 3H), 1.53 (d, 6H), 2.80 (s, 3H), 2.85 (q, 2H), 3.32 (m, 4H), 5.58 (m, 1H),7.21 (d, 1H), 7.52 (t, 1H), 7.73 (d, 2H), 7.86 (d, 2H), 8.39 (s, 1H), 8.68 (d, 1H), 10.18 (brs, 1H)
Sources & evidence
- ORD record
- ord-dc19a93e847544129731cf2756e91cdc
- Source dataset
- uspto-grants-2008_12
- Patent number
- US07465728B2
Reaction notes
Loading…